Stifel analyst James Condulis reiterated a Buy rating and $104.00 price target on Arrowhead Pharma (NASDAQ: ARWR).The analyst commented, "Detailed ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments